Key facts
- It has raised $390K; the latest was Angel (individual) ($240K) in Oct 2025.
- Notable investors include MassChallenge, Harvard Innovation Launch Lab, MIT Solve, Greenshot Accelerator, UMass Lowell.
- Pacto Medical has filed 1 Form D with the SEC, most recently Jul 2024 ($153K sold to 5 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Pacto Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Pacto Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pacto Medical
Manufacturer of pre-filled syringes intended to reduce storage space and waste. The company's syringes feature a plunger that folds alongside the syringe body during transport and compact packaging, reducing shipping and storage costs, enabling healthcare workers to ship and deliver more hypodermic needles for less money and with lower environmental impact.
- Sector
- Healthcare
- HQ
- Newark, DE, United States
- Founded
- 2023
- Employees
- 5
- Website
- pactomedical.com/
- Ownership
- Privately Held (backing)
Pacto Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pacto Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pacto Medical in its N-PORT filings yet. We sweep new filings monthly.